||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [Z] 501 active entries
Królowej Jadwigi 33/3B
Phone: +48 507 470 880, +4812 2663910
Fax: 012 2663911
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
click here for BioTe21 offer - genetic diagnostics in molecular medicine.
BioTe21 is a biotech SME with the experience in the field of molecular medicine, development of new genetic diagnostics and innovative biotechnologies. Laboratory of BioTe21 are interested in elaboration of a new generation of therapeutics based on small interfering RNAs genes and recombinant proteins. Our company is co-financed by the European Union from the European Regional Development Fund (ERDF) as part of the Integrated Regional Operational Programme (IROP) and is located at Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University. Laboratory is equipped with the most advanced research tools and high-resolution apparatus enable of performing the synthesis and analysis at genome and transcryptome level..
Our basic activities are divided into three main areas:
- nucleic acid synthesis and sequencing
at Laboratory of Nucleic Acid Synthesis and Sequencing
- genetic identification and paternity testing
at Laboratory of Genetic Identification,
- elaboration and implementation of innovative biotechnologies which are applied to molecular medicine and genetic diagnostics
at Laboratory of Biotechnology,
Genetic diagnostics in molecular medicine:Our newest technologies: SNP-based detection of predisposition to: UV-dependent melanoma malignum (MC1R), breast cancer (BRCA1, BRCA2) , lung cancer, thyroid cancer, colon cancer as well as many other diseases.
We recommend also our :
- - Analytical
Last update of this entry: September 27, 2016